Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2025-12-26 @ 8:49 PM
Study NCT ID:
NCT01342692
Status:
UNKNOWN
Last Update Posted:
2019-02-19
First Post:
2011-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Best Promising Drug Association With Azacitidine in Higher Risk Myelodysplastic Syndromes
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-06
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06
Completion Date Type:
ESTIMATED
First Submit Date:
2011-04-21
First Submit QC Date:
None
Study First Post Date:
2011-04-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-18
Last Update Post Date:
2019-02-19
Last Update Post Date Type:
ACTUAL